PDCD1 and melanoma: Immune checkpoint inhibitors, particularly anti-Cytotoxic T lymphocyte-associatedantigen-4 (CTLA4) and anti-Programmed cell death protein-1 (PD-1) antibodies, have revolutionized the treatment of many cancers, including advanced melanomas (7).